Shak Steven 4
4 · GENOMIC HEALTH INC · Filed Aug 7, 2019
Insider Transaction Report
Form 4
Shak Steven
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-08-05$71.22/sh−22,529$1,604,585→ 111,266 total(indirect: By Trust) - Sale
Common Stock
2019-08-06$72.14/sh−16,860$1,216,243→ 91,935 total(indirect: By Trust) - Sale
Common Stock
2019-08-05$71.85/sh−2,471$177,544→ 108,795 total(indirect: By Trust) - Sale
Common Stock
2019-08-06$72.86/sh−8,140$593,088→ 83,795 total(indirect: By Trust)
Footnotes (7)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 3, 2019.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $70.72 to $71.71.
- [F4]Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F5]Represents weighted average sale price. Actual sale prices ranged from $71.73 to $72.14.
- [F6]Represents weighted average sale price. Actual sale prices ranged from $71.61 to $72.59.
- [F7]Represents weighted average sale price. Actual sale prices ranged from $72.61 to $73.14.